Back to HRTX

UBS Group AG → HRTX

UBS Group AG HRTX Position History

Heron Therapeutics, Inc. • Healthcare

Quarters held
15
Latest value
$29K
Q3 2026
Peak value
$3.7M
First seen
Q3 2025

Dollar value over time

Show data table
PeriodPosition value
Q3 2025$12K
Q3 2025$3.7M
Q3 2025$6K
Q4 2025$13K
Q4 2025$2.7M
Q4 2025$47K
Q1 2026$9K
Q1 2026$1.8M
Q2 2026$6K
Q2 2026$1.3M
Q2 2026$9K
Q3 2026$2K
Q3 2026$627K
Q3 2026$3K
Q3 2026$29K

Quarter-by-quarter history

Every disclosed snapshot of the position

QuarterValueShares% PortfolioChange
Q3 2026$29K91.1K——
Q3 2026$3K8.8K——
Q3 2026$627K2.00M——
Q3 2026$2K7.0K——
Q2 2026$9K21.7K——
Q2 2026$1.3M2.96M——
Q2 2026$6K14.0K——
Q1 2026$1.8M2.27M——
Q1 2026$9K11.7K——
Q4 2025$47K36.5K——
Q4 2025$2.7M2.05M——
Q4 2025$13K9.8K——
Q3 2025$6K4.4K——
Q3 2025$3.7M2.92M——
Q3 2025$12K9.8K——

Other funds holding HRTX

Other UBS Group AG positions

MSFT

MICROSOFT CORP

$8.1B
AAPL

APPLE INC

$7.8B
NVDA

NVIDIA CORPORATION

$7.8B
AAPL

APPLE INC

$7.7B
NVDA

NVIDIA CORPORATION

$7.7B
MSFT

MICROSOFT CORP

$7.6B
MSFT

MICROSOFT CORP

$7.4B
NVDA

NVIDIA CORPORATION

$7.3B